Influence of opiate tolerance and calcium channel antagonists on the antinociceptive effects of L-arginine and N(G)-nitro-L-arginine

General Pharmacology

Volumn 28, Issue 3, 1997, Pages 443-448

  Contreras, Enrique ^a   Germany, Aniza ^a   Gonzalez, Paulo ^a   Norris, Beryl ^a  

^a UNIVERSITY OF CONCEPCIÓN   (Chile)

Author keywords

antinociception; calcium channel antagonists; L arginine; N(G) nitro L arginine; opiates

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; ARGININE; CALCIUM ANTAGONIST; DEXTRO ARGININE; DILTIAZEM; MORPHINE; N(G) NITROARGININE; NALOXONE; NITRIC OXIDE; OPIATE; PENTAZOCINE; VERAPAMIL;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG MECHANISM; DRUG POTENTIATION; DRUG TOLERANCE; HOT PLATE TEST; MALE; MORPHINE TOLERANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ANALGESIA; ANALGESICS, OPIOID; ANIMALS; ARGININE; CALCIUM CHANNEL BLOCKERS; DILTIAZEM; DRUG TOLERANCE; ENZYME INHIBITORS; MALE; MICE; MORPHINE; NITRIC OXIDE SYNTHASE; NITROARGININE; PAIN MEASUREMENT; PENTAZOCINE; VERAPAMIL;

EID: 0031056976     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(96)00295-9     Document Type: Article

References (23)

1. Babey A.-M., Kolesnikov Y., Cheng J., Iturrisi C. E., Trifilletti R. R. and Pasternak G. W. (1994) Nitric oxide and opioid tolerance Neuropharmacology 33, 1463-1470.
2. Bredt D. S. and Snyder S. H. (1990) Isolation of nitric oxide synthetase, a caldmodulin-requiring enzyme. Proc. Natl. Acad. Sci. USA 87, 682-685.
3. Bredt D. S. and Snyder S. H. (1994) Nitric oxide: a physiologic messenger molecule. Ann. Rev. Biochem. 63, 175-195.
4. Contreras E., Tamayo L. and Amigo M. (1988) Calcium channel antagonists increase morphine induced analgesia and antagonize morphine tolerance. Eur. J. Pharmacol. 148, 463-466.
5. Contreras E., Quijada L., Germany A., Fleckenstein R. and Hernández A. (1993) Calcium channel antagonists and adenosine analogues decrease tolerance to opiates pentazocine and U50488H. Gen. Pharmacol. 24, 1203-1206.
6. Dambisya Y. M. and Lee T.-L. (1996) Role of nitric oxide in the induction and expression of morphine tolerance and dependence in mice. Br. J. Pharmacol. 117, 914-918.
7. Dierssen M., Flórez, J. and Hurlé M. A. (1990) Calcium channel modulation by dihydropyridines modifies sufentanil-induced antinociception in acute and tolerant conditions. Naunyn Schmiedebergs Arch. Pharmacol. 342, 559-565.
8. Eddy N. B. and Leimbach D. J. (1953) Synthetic analgesics II dithienylbutenyl and dithienylbutyl amines. J. Pharmacol. Exp. Ther. 107, 385-393.
9. G-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa-opioids, Pain 56, 69-75.
10. Haley J. E., Dickenson A. H. and Schachter M. (1992) Electrophysiological evidence for a role of nitric oxide in prolonged chemical nociception in the rat. Neuropharmacology 31, 251-258.
11. Harima A., Shimizu H., and Takagi H. (1991) Analgesic effect of L-arginine in patients with persistent pain. Eur. Neuropsychopharmacol. 1, 529-533.
12. Hirsch D. B., Steiner J. P., Dawson T. M., Mammen A., Hayek E. and Snyder S. H. (1993) Neurotransmitter release regulated by nitric oxide in PC-12 cells and brain synapsotomes. Current Biol. 3, 749-754.
13. Iwamoto E. T. and Marion L. (1994) Pharmacologic evidence that spinal muscarinic analgesia is mediated by an L-arginine/nitric oxide/cyclic GMP cascade in rats. J. Pharmacol. Exp.Ther. 271, 601-608.
14. Kawabta A., Fukuzumi Y., Fukushima Y. and Takagi H. (1992) Antinociceptive effect of L-arginine on the carrageenin-induced hyperalgesia of the rat: possible involvement of central opiopeptidergic systems. Eur. J. Pharmacol 218, 153-158.
15. Kawabata A., Umeda N. and Takagi H. (1983) L-arginine exerts a dual role in nociception processing in the brain: involvement of the kyotorphinmet-enkephalin pathway and NO-cyclic GMP pathway. Br. J. Pharmacol. 109, 73-79.
16. Levy R. A., Proudfit H. K. and Goldstein B. D. (1983) Antinociception following microinjection of dibutyryl cyclic nucleotides into the caudal reticular formation and periaqueductal grey of the rat brain. Pharmacol. Biochem. Behav. 19, 79-84.
17. McDonald C. E., Gagnon M. J., Ellenberger E. A., Hodges B. L., Ream J. K., Tousman S. A. and Quock R. M. (1994) Inhibitors of nitric oxide synthesis antagonize nitrous oxide antinociception in mice and rats. J. Pharmacol. Exp. Ther. 269, 601-608.
18. G-nitroarginine methyl ester exhibits antinociceptive activity in the mouse. Br. J. Pharmacol. 102, 192-202.
19. Morris R., Southan E., Braid D. J. and Garthwaite J. (1992) Nitric oxide may act as a messenger between dorsal root ganglia neurones and their satellite cells. Neurosci. Lett. 137, 29-32.
20. Takagi H., Shiomi H, Ueda H. and Amano H. (1979) A novel analgesic dipeptide from bovine brain is a possible Me-enkephalin releaser. Nature 282, 410-412.
21. Tseng L. F., Xu J. Y. and Pieper G. M. (1992) Increase of nitric oxide production by L-arginine potentiates i.c.v. administered β-endorphin-induced antinociception in mice. Eur. J. Pharmacol. 21, 301-303.
22. Ueda H., Yoshihara Y., Fukushima N., Shiomi H., Nakamura A. and Takagi H. (1997) Kyotorphin (tyrosyl-arginine) synthetase in rat brain synaptosomes. J. Biol. Chem. 262, 8165-8173.
23. Xu J. Y. and Tseng L. F. (1993) Increase of nitric oxide by L-arginine potentiates β-endorphin but not m, d or k-opioid agonist-induced antinociception in the mouse. Eur. J. Pharmacol. 236, 137-142.